Ketamine and Integration: The Good, The Bad, and the Ugly
A Talk by Julia Mirer , Hannah McLane MD, MA, MPH and Kazi Hassan
About this Talk
Ketamine is legally available for use in psychedelic therapy, but without many guidelines, it is offered in different forms, at different doses, in different settings, and with varying degrees of therapy and support.
Although it isn’t a “classic” psychedelic, it is in a unique position to pave the way for the ones that are. If what we do with ketamine is successful, then other psychedelics coming online can follow a working model.
In our panel, we will hear from experts about the pitfalls of ketamine therapy, the potential risks of addiction, what integration looks like with ketamine, and discuss possible ways to get equitable access to those in need.
About The Speakers
Chief Education Officer, Mr. Psychedelic Law
Dr. Julia Mirer MD is a consultant in the emerging field of psychedelic medicine, serving as a bridge between eastern and western practices, committed to merging the two in order to help create a new paradigm for integrative health and wellness.
Founder, SoundMind Center Philadelphia
Dr. McLane holds degrees from McGill University (BA, International Development Studies), Temple University (MA, Communication Sciences), Brown University (MD, Doctor of Medicine), and Harvard School of Public Health (MPH, Global health and Bioethics).